The Business Times
business-time-50

Tikehau Capital, Sprim join forces with new S'pore-based life sciences VC fund

google-preferred-sourceAdd BT as a preferred source
Annabeth Leow

Annabeth Leow

Published Sun, Mar 11, 2018 · 09:50 PM

    Singapore

    LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for funding.

    European asset manager Tikehau Capital and Sprim Ventures, the venture arm of global healthcare consultancy Sprim, have teamed up to launch a venture capital (VC) fund for early-stage investments.

    Venture capitalLife sciencesTikehau CapitalStartups

    TRENDING NOW

    Grant Wee built Hideaway as a massage-and-bathhouse concept centred on solitude and recovery.

    UOB CEO’s youngest child Grant Wee turns burnout into a wellness business

    HSBC Singapore CEO Wong Kee Joo says the expansion “reflects our confidence in the country’s future as a leading wealth, trade, and innovation hub”.

    Wanted: 100 AI specialists, 100 wealth relationship managers at HSBC Singapore

    This marks the second-largest initial public offering in China’s history.

    China chipmaker CXMT jumps 472% in debut after US$9.8 billion IPO

    A combined CapitaLand-Mapletree group would be better positioned to compete, and it would raise the profile of the Singapore market.

    Temasek should publicly state its position on the long-rumoured CapitaLand-Mapletree merger

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More